Dermatomyositis syndrome in small cell lung cancer
- Authors: Musin ST1, Berezhnoy SG1, Khrapova IA1, Romanovskaya EV1, Ovsyannikov NV2, Drokina OV2
-
Affiliations:
- Clinical Medical and Surgical Center
- Omsk State Medical University
- Issue: Vol 101, No 6 (2020)
- Pages: 913-918
- Section: Clinical observations
- URL: https://kazanmedjournal.ru/kazanmedj/article/view/43936
- DOI: https://doi.org/10.17816/KMJ2020-913
- ID: 43936
Cite item
Abstract
Dermatomyositis is a progressive systemic disease clinically manifested by a muscle lesion with impaired motor function as well as skin rashes, often in the form of erythema. In some cases, dermatomyositis can be the onset of cancer. In this regard, the doctor is required to be highly alert and focused on detecting the tumor process in patients with progressive muscle weakness and characteristic skin manifestations of dermatomyositis. The article presents a clinical case of paraneoplastic dermatomyositis co‐existing with small cell lung cancer. The malignancy was dia¬gnosed during cancer screening in a patient with classic manifestations of dermatomyositis. Improvement of clinical manifestations of dermatomyositis appeared with glucocorticosteroid therapy and surgical treatment, but the patient died, since small cell lung cancer has an aggressive clinical course with an unfavorable prognosis.
Full Text
About the authors
S T Musin
Clinical Medical and Surgical Center
Email: amans@bk.ru
Omsk, Russia
S G Berezhnoy
Clinical Medical and Surgical Center
Email: amans@bk.ru
Russian Federation, Omsk, Russia
I A Khrapova
Clinical Medical and Surgical Center
Email: amans@bk.ru
Russian Federation, Omsk, Russia
E V Romanovskaya
Clinical Medical and Surgical Center
Email: amans@bk.ru
Russian Federation, Omsk, Russia
N V Ovsyannikov
Omsk State Medical University
Email: amans@bk.ru
Russian Federation, Omsk, Russia
O V Drokina
Omsk State Medical University
Author for correspondence.
Email: amans@bk.ru
Russian Federation, Omsk, Russia
References
- El-Azhary R.A., Pakzad S.Y. Amyopathic dermatomyositis: retrospective review of 37 cases. J. Am. Acad. Dermatol. 2002; 46: 560‒565. doi: 10.1067/mjd.2002.120620.
- Chu L.L., Rohekar G. Dermatomyositis. CMAJ. 2019; 191 (12): E340. doi: 10.1503/cmaj.180947.
- Callen J., Wortmann R. Dermatomyositis. Clin. Dermatol. 2006; 24 (5): 363–373. doi: 10.1016/j.clindermatol.2006.07.001.
- Bohan A., Peter J.B., Bowman R.L., Pearson C.M. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977; 56 (4): 255–286. doi: 10.1097/00005792-197707000-00001.
- Tymms K.E., Webb J. Dermatopolymyositis and other connective tissue diseases: A review of 105 cases. J. Rheumatol. 1985; 12 (6): 1140–1148. PMID: 4093921.
- Орлова Е.В., Плиева Л.Р., Пятилова П.М., Новосартян М.Г. Дерматомиозит: клинический случай и обзор литературы. Рус. мед. ж. 2017; 25 (11): 850–852. [Orlova E.V., Plieva L.R., Pyatilova P.M., Novosartian M.G. Dermatomyositis: a clinical case and literature review. Russkiy meditsinskiy zhurnal. 2017; 25 (11): 850–852. (In Russ.)]
- Radenska-Lopovok S.G. Morphological differential diagnosis of the main types of inflammatory myopathies. Nervno-myshechnye bolezni. 2012; (1): 7‒11. (In Russ.)
- Rodionov A.N. Dermatovenerologija. (Dermatovenereology.) Polnoe rukovodstvo dlja vrachej. SPb.: Nauka i tehnika. 2014; 872 p. (In Russ.)
- Okorokov A.N. Diagnostika bolezney vnutrennikh organov. Tom 2. (Diagnosis of diseases of internal organs. Vol. 2.) M.: MedLit. 2004; 566 p. (In Russ.)
- Hill C., Zhang Y., Sigurgeirsson B. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001; 357 (9250): 96–100. doi: 10.1016/S0140-6736(00)03540-6.
- Smirnova A.A., Simonova O.V. Paraneoplastic dermatomyositis: description of clinical case. Farmateka. 2018; (S2): 72–74. (In Russ.) doi: 10.18565/pharmateca.2018.s2.72-74.
- Mazurova V.I. Diffuznye bolezni soedinitel'noy tkani. (Diffuse diseases of connective tissue.) A guide for doctors. St. Petersburg: Special Lit. 2009; 192 p. (In Russ.)
- Milone M. Diagnosis and management of immune-mediated myopathy. Mayo Clin. Proc. 2017; 92 (5): 826–837. doi: 10.1016/j.mayocp.2016.12.025.
- Ganshina I.P., Zhukova L.G., Burnevitch E.Z. et al. Dermatomyositis and polymyositis in breast cancer patients: a case reports. Sovremennaya onkologiya. 2018; 20 (1): 42–44. (In Russ.)
- Choy E., Isenberg D. Treatment of dermatomyositis and polymyositis. Rheumatology. 2002; 41 (1): 7–13.
- Dikareva E.A., Velichinskaya O.G. Dermatomyositis (clinical case). Vestnik VGMU. 2019; 18 (2): 116–122. (In Russ.) doi: 10.22263/2312-4156.2019.2.116.
- Zykova A.S., Novikov P.I., Moiseev S.V. Adult dermatomyositis: new classification criteria and modern treatment. Klinicheskaya farmakologiya. 2017; 26 (2): 83–92. (In Russ.)
- Antelava O.A. The specific features of the onset, clinical picture, steroid responsiveness of paraneoplastic myositis. Rheumatology Science and Practice. 2013; (2): 181–185. (In Russ.) doi: 10.14412/1995-4484-2013-647.
- Ankudinov A.S., Kalyagin A.N., Chernykh S.Yu. Paraneoplastic myositis. Sibirskiy meditsinskiy zhurnal (Irkutsk). 2013; (3): 120–123. (In Russ.)
- Antiochos B., Brown L., Li Z. Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA. J. Rheumatol. 2009; 36 (12): 2704–2710. doi: 10.3899/jrheum.090549.
- Sigurgeirsson B., Lindelof B., Edhag O. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N. Eng. J. Med. 1992; 326 (6): 363–367. doi: 10.1056/NEJM199202063260602.
- Stockton D., Doherty V., Brewster D. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br. J. Cancer. 2001; 85 (1): 41–45. doi: 10.1054/bjoc.2001.1699.
- Minimum clinical recommendations of the European Society for Medical Oncology (ESMO). Ed. by (Russian translation) S.A. Tyulyandin, D.A. Nosov, N.I. Perevodchikova. M.: Publication. RONC group named after N.N. Blokhin RAMS. 2010; 170–186 p. (In Russ.)